Synthesis and in vitro and in vivo characterization of highly beta1-selective beta-adrenoceptor partial agonists

Shailesh Natvarbhai Mistry, Jillian G Baker, Peter M Fischer, Stephen J Hill, Sheila M Gardiner, Barrie Kellam

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)


?-Adrenoceptor antagonists boast a 50-year use for symptomatic control in numerous cardiovascular diseases. One might expect highly selective antagonists are available for the human ?-adrenoceptor subtype involved in these diseases, yet few truly ?1-selective molecules exist. To address this clinical need, we re-evaluated LK 204-545 (1),(1) a selective ?1-adrenoceptor antagonist, and discovered it possessed significant partial agonism. Removal of 1 s aromatic nitrile afforded 19, a ligand with similar ?1-adrenoceptor selectivity and partial agonism (log KD of -7.75 and -5.15 as an antagonist of functional ?1- and ?2-mediated responses, respectively, and 34 of the maximal response of isoprenaline (?1)). In vitro ?-adrenoceptor selectivity and partial agonism of 19 were mirrored in vivo. We designed analogues of 19 to improve affinity, selectivity, and partial agonism. Although partial agonism could not be fully attenuated, SAR suggests that an extended alkoxyalkoxy side chain, alongside substituents at the meta- or para-positions of the phenylurea, increases ligand affinity and ?1-selectivity.
Original languageEnglish
Pages (from-to)3852 - 3865
Number of pages14
JournalJournal of Medicinal Chemistry
Issue number10
Publication statusPublished - 2013
Externally publishedYes

Cite this